Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-009812
Filing Date
2025-02-06
Accepted
2025-02-06 06:30:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm255282d2_424b5.htm 424B5 406170
2 GRAPHIC tm255282d1_424b5img001.jpg GRAPHIC 3278
  Complete submission text file 0001104659-25-009812.txt   411840
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270657 | Film No.: 25595350
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)